Richard Podell

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source:LinkedIn

Richard Podell, M.D., MPH, is a Clinical Professor at Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey and had a private practice where he saw ME/CFS, Fibromyalgia and other patients. He practiced integrated medicine in Summit, NJ but is retired as of September 1, 2017. He was a provider of Ampligen during one of its earlier trials.

In 2002, Podell was a member of the writing committee for A Consensus Manual for the Primary Care and Management of Chronic Fatigue Syndrome, a clinical care manual produced by The Academy of Medicine of New Jersey and the New Jersey Department of Health and Senior Services.[1]

Dr. Podell provides updates in research and treatment options via his YouTube channel: Chronic Fatigue and Fibromyalgis Update with Dr. Richard Podell

Education[edit | edit source]

  • M.D. - Harvard Medical School

Writing committees[edit | edit source]

Advocacy[edit | edit source]

Open Letter to The Lancet[edit | edit source]

Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Podell, along with 41 colleagues in the ME/CFS field, signed the second letter.

Talks and interviews[edit | edit source]

Chronic Fatigue and Fibromyalgis Update with Dr. Richard Podell[edit | edit source]

Ginevra Liptan

Kim Jones

Alan Light

Studies and articles[edit | edit source]

Online presence[edit | edit source]

References[edit | edit source]

  1. 1.01.1 John, Joseph F.; Oleske, James, eds. (2002). A Consensus Manual for the Primary Care and Management of Chronic Fatigue Syndrome. New Jersey: The Academy of Medicine of New Jersey, The New Jersey Department of Health & Senior Services. 
  2. Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029 
  3. Comerford, Barbara B.; Podell, Richard (Jul 2, 2019). "Medically Documenting Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Cases". Frontiers in Pediatrics. 7: 231. doi:10.3389/fped.2019.00231. ISSN 2296-2360. PMC 6615314Freely accessible. PMID 31334205. 

Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.